Search Results 81-90 of 28360 for Adenocarcinoma

  1. Atypical cells: Are they cancer? - Mayo Clinic

    Do atypical cells usually mean cancer? Answer From Tatnai Burnett, M.D.. On occasion you may see a report from a Pap test or tissue biopsy stating "atypical ...

  2. Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma. Print details. Share; Facebook ...

  3. Study of Validated Biomarkers in Urine for Patients with Adenocarcinoma of the Prostate - Mayo Clinic

    Clinical Trials · Study of Validated Biomarkers in Urine for Patients with Adenocarcinoma of the Prostate · More about research at Mayo Clinic · Mayo Clinic Footer.

  4. Convolutional neural network trained to distinguish autoimmune pancreatitis from pancreatic ductal adenocarcinoma and benign pancreas conditions - Mayo Clinic

    Differentiating AIP from pancreatic ductal adenocarcinoma (PDAC) can be difficult due to similarities in clinical presentation and sonographic and cross- ...

  5. Neuroendocrine tumors - Symptoms and causes - Mayo Clinic

    Learn about the types of tumors that make up this group of rare cancers. Find out about symptoms, causes, diagnosis and treatments.

  6. Breast cancer types: What your type means - Mayo Clinic

    This type includes tumors that are ER positive, PR negative and HER2 positive. Luminal B breast cancers are likely to benefit from chemotherapy and may benefit ...

  7. A Study of an Integrated Approach to Treating Recurrent Lung Adenocarcinomas Resistant to Tyrosine Kinase Inhibitors - Mayo Clinic

    A Study of an Integrated Approach to Treating Recurrent Lung Adenocarcinomas Resistant to Tyrosine Kinase Inhibitors · Overview · Participation eligibility.

  8. Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma. Print details.

  9. A Study of Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma - Mayo Clinic

    Clinical Trials · A Study of Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma · More about research at ...

  10. Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) - Mayo Clinic

    Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab- ...